Lack of association between serum adiponectin levels and the Pro12Ala polymorphism in Asian Indians

Diabetic Medicine

Volumn 24, Issue 4, 2007, Pages 398-402

  Radha, V ^a   Vimaleswaran, K S ^a   Babu, S ^b   Deepa, R ^a   Anjana, M ^a   Ghosh, S ^c   Majumder, P P ^c   Rao, M R S ^b   Mohan, V ^a  

^a MADRAS DIABETES RESEARCH FOUNDATION   (India)

^b INDIAN INSTITUTE OF SCIENCE   (India)

^c INDIAN STATISTICAL INSTITUTE   (India)

Author keywords

Adiponectin; Asian Indians; Chennai Urban Rural Epidemiology Study; Pro12Ala polymorphism; Type 2 diabetes

Indexed keywords

ADIPONECTIN; ALANINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROLINE;

ADULT; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; GLUCOSE TOLERANCE; HUMAN; INDIAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RADIOIMMUNOASSAY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADIPONECTIN; ADULT; ALANINE; ASIAN CONTINENTAL ANCESTRY GROUP; DIABETES MELLITUS; EPIDEMIOLOGIC STUDIES; FEMALE; GENOTYPE; GLUCOSE TOLERANCE TEST; HUMANS; INDIA; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PPAR GAMMA; PROLINE;

EID: 33947415800     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2006.02069.x     Document Type: Article

References (25)

1. Spiegelman BM. PPAR-γ: adipogenic regulator and thiazolidinedione receptor. Diabetes 1998; 47: 507-514.
2. Yang WS, Jeng CY, Wu TJ, Tanaka S, Funahashi T, Matsuzawa Y et al. Synthetic peroxisome proliferator-activated receptor-γ agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients. Diabetes Care, 2002; 25: 376-380.
3. Hara K, Okada T, Tobe K, Yasuda K, Mori Y, Kadowaki H et al. The Pro12Ala polymorphism in PPAR 2 may confer resistance to type 2 diabetes. Biochem Biophys Res Commun 2000; 271: 212-216.
4. Meirhaeghe A, Fajas L, Helbecque N, Cottel D, Auwerx J, Deeb SS et al. Impact of the peroxisome proliferator-activated receptor 2 Pro12Ala polymorphism on adiposity, lipids and non-insulin-dependent diabetes mellitus. Int J Obes Relat Metab Disord 2000; 24: 195-199.
5. Swarbrick MM, Chapman CM, McQuillan BM, Hung J, Thompson PL, Beilby JP. A Pro12Ala polymorphism in the human peroxisome proliferators-activated receptor-2 is associated with combined hyperlipidaemia in obesity. Eur J Endocrinol, 2001; 144: 277-282.
6. Deeb SS, Fajas L, Nemoto M, Pihlajamaki J, Mykkanan L, Kuusisto J et al. A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet 1998; 20: 284-287.
7. Yamamoto Y, Hirose H, Miyashita K, Nishikai K, Saito I, Taniyama M et al. PPARγ2 gene Pro12Ala polymorphism may influence serum level of an adipocyte-derived protein, adiponectin, in the Japanese population. Metabolism 2002; 51: 1407-1409.
8. Thamer C, Machicao F, Fritsche A, Stumvoll M, Haring H. No influence of the PPARγ2 Pro12Ala genotype on serum adiponectin concentrations in healthy Europeans. Metabolism 2003; 52: 798-799.
9. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes, estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-1053.
10. Sharp PS, Mohan V, Levy JC, Mather HM, Kohner EM. Insulin resistance in patients of Asian Indian and European origin with non-insulin dependent diabetes. Horm Metab Res 1987; 19: 84-85.
11. Chandalia M, Abate N, Garg A, Stray-Gundersen J, Grundy SM. Relationship between generalized and upper body obesity to insulin resistance in Asian Indian men. J Clin Endocrinol Metab 1999; 84: 2329-2335.
12. Abate N, Chandalia M, Snell PG, Grundy SM. Adipose tissue metabolites and insulin resistance in non-diabetic Asian Indian men. J Clin Endocrinol Metab 2004; 89: 2750-2755.
13. Deepa M, Pradeepa R, Rema M, Mohan A, Deepa R, Shanthirani S et al. The Chennai Urban Rural Epidemiology Study (CURES) - study design and methodology (urban component) (CURES-1). J Assoc Physicians India 2003; 51: 863-870.
14. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment. insulin resistance and β cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
15. Abate N, Chandalia M. Ethnicity and type 2 diabetes: focus on Asian Indians. J Diabetes Complications 2001; 15: 320-327.
16. McKeigue PM, Pierpoint T, Ferrie JE, Marmot MG. Relationship of glucose intolerance and hyperinsulinaemia to body fat pattern in south Asians and Europeans. Diabetologia 1992; 35: 785-791.
17. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998; 21: 1414-1431.
18. Mohan V, Sharp PS, Cloke HR, Burrin JM, Schumer B, Kohner EM. Serum immunoreactive insulin responses to glucose load in Asian Indian and European type 2 (non-insulin-dependent) diabetic patients and control subjects. Diabetologia 1986; 29: 235-237.
19. Mohan V, Deepa R, Vimaleswaran KS, Mohan A, Velmurugan K, Radha V. Association of low adiponectin levels with the metabolic syndrome - The Chennai Urban Rural Epidemiology study (CURES-4). Metabolism 2005; 54: 476-481.
20. Iwaki M, Matsuda M, Maeda N, Funahashi T, Matsuzawa Y, Makishima M et al. Induction of adiponectin, a fat-derived anti-diabetic and anti-atherogenic factor, by nuclear receptors. Diabetes 2003; 52: 1655-1663.
21. Mori H, Ikegami H, Kawaguchi Y, Seino S, Yokoi N, Takeda J et al. The Pro12Ala substitution in PPAR-γ is associated with resistance to development of diabetes in the general population: possible involvement in impairment of insulin secretion in individuals with type 2 diabetes. Diabetes 2001; 50: 891-894.
22. Hara M, Alcoser SY, Qaadir A, Beiswenger KK, Cox NJ, Ehrmann DA. Insulin resistance is attenuated in women with polycystic ovary syndrome with the Pro12Ala polymorphism in the PPAR gene. J Clin Endocrinol Metab 2002; 87: 772-775.
23. Stumvoll M, Wahl HG, Loblein K, Becker R, Machicao F, Jacob S et al. Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-2 gene is associated with increased anti-lipolytic insulin sensitivity. Diabetes 2001; 50: 876-881.
24. Beamer BA, Yen CJ, Andersen RE, Muller D, Elahi D, Cheskin LJ et al. Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-2 gene with obesity in two Caucasian populations. Diabetes 1998; 47: 1806-1808.
25. Altshuler D, Hirschhorn JN, Klannemark M, Lindgren CM, Vohl MC, Nemesh J et al. The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet, 2000; 26: 76-80.